MedPath

SPECIALISED THERAPEUTICS ASIA PTE. LTD.

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

HSA:7

Drug Approvals

PEMAZYRE TABLETS 13.5 MG

Approval Date
Jul 9, 2024
HSA

PEMAZYRE TABLETS 9 MG

Approval Date
Jul 9, 2024
HSA

PEMAZYRE TABLETS 4.5 MG

Approval Date
Jul 9, 2024
HSA

QINLOCK TABLET 50 MG

Approval Date
Apr 28, 2023
HSA

ZEPZELCA POWDER FOR SOLUTION FOR INFUSION 4MG/VIAL

Approval Date
Sep 21, 2021
HSA

NERLYNX FILM-COATED TABLETS 40 MG

Approval Date
Nov 25, 2019
HSA

YONDELIS Powder for Injection 1mg/vial

Approval Date
Jun 19, 2009
HSA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.